Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review ID - 433210 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433210/all/Addition_of_long_acting_beta2_agonists_to_inhaled_steroids_versus_higher_dose_inhaled_steroids_in_adults_and_children_with_persistent_asthma:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -